Dallas, TX 的 憂鬱症 臨床試驗
12 項針對 憂鬱症 的研究正在 Dallas（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
招募中2 期
- FutureSearch Trials of Dallas, Dallas
Parent-Adolescent Relationships, Emotional Regulation, and HRV in Adolescents With Depression
招募中觀察性研究
- Child and adolescent psychiatrist at the Children's Health Psychiatry Clinic., Dallas
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
招募中2 期
- Seaport Investigator Site, Dallas
Accelerated rTMS for Substance Use Disorder and Depression
招募中
- UT Southwestern Medical Center, Dallas
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
招募中3 期
- Relaro Medical Trials /ID# 227156, Dallas
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Dallas
Preventing Vulnerable Child Syndrome in the NICU With Cognitive Behavioral Therapy (PreVNT Trial)
招募中歡迎健康志工
- Parkland Health & Hospital System, Dallas
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
招募中
- University of Texas Southwestern, Dallas
Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O)
招募中
- UT Southwestern Parkland Health and Hospital System, Dallas
Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care
招募中
- University of Texas Southwestern Medical Center, Dallas
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Dallas
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
招募中4 期
- Clinical Research Site, Dallas
- Clinical Research Site, Dallas
其他城市的 憂鬱症 試驗
- Boston, MA52 項研究
- New York City, NY45 項研究
- Philadelphia, PA26 項研究
- Atlanta, GA24 項研究
- Chicago, IL24 項研究
- Pittsburgh, PA22 項研究
- San Diego, CA21 項研究
- Charleston, SC19 項研究
- Houston, TX18 項研究
- Orlando, FL17 項研究
- Los Angeles, CA17 項研究
- Miami, FL16 項研究
Dallas 的其他研究
- 乳癌55 項研究
- 非小細胞肺癌52 項研究
- 轉移性癌症42 項研究
- 心臟衰竭42 項研究
- 癌症（所有類型）37 項研究
- 前列腺癌36 項研究
- 大腸直腸癌33 項研究
- 肥胖症30 項研究
- 卵巢癌28 項研究
- 膀胱癌27 項研究
- 肺癌27 項研究
- 子宮內膜癌24 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。